Peyronie's disease (PD) is known to be associated with Dupuytren's disease (DD) since 1828. The aim of this study was to investigate the coexistence of DD in a consecutive series of patients with PD and their clinical characteristics. From January 1988 to December 2009 all patients, presenting at our outpatient urological clinic, with PD were also examined for DD. The sample consisted of 415 male subjects with PD, 89 (22.1%) also had DD. A total of 28 men (6.7%) reported to have one or more first or second degree relatives with DD.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Tijdschrift voor Urologie Open Access 14 November 2018
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Trost LW, Gur S, Hellstrom WJG . Pharmacological management of Peyronie's disease. Drugs 2007; 67: 527–545.
Ralph DJ, Minhas S . The management of Peyronie's disease. BJU Int 2004; 93: 208–215.
Shaw K, Puri K, Ruiz-Deya G, Hellstrom WJG . Racial considerations in the evaluation of Peyronie's disease. J Urol 2001; 165 170: 687A.
Sommer F, Schwarzer U, Wassmer G, Bloch W, Braun M, Klotz T et al. Epidemiology of Peyronie's disease. Int J Impot Res 2002; 14: 379–383.
Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT . The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991; 146: 1007–1009.
Greenfield JM, Levine LA . Peyronie's disease: etiology, epidemiology and medical treatment. Urol Clin N Am 2005; 32: 469–478.
Abernethy J . The Consequences of Gonorrhea. Lecture on Anatomy, Surgery and Pathology: Including Observations on the Nature and Treatment of Local Diseases, Delivered at St Bartholomew's and Christ's Hospitals. 1st edn. James Balcock: London (England), 1828 pp. 205.
Ling RS . The genetic factor in Dupuytren's disease. J Bone Joint Surg 1963; 45: 709.
Ralph DJ, Schwartz G, Moore W, Pryor JP, Ebringer A, Bottazzo GF . The genetic and bacteriological aspects of Peyronie's disease. J Urol 1997; 157: 291–294.
Nyberg Jr LM, Bias WB, Hochberg MC, Walsh PC . Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. J Urol 1982; 128: 48–51.
Vi L, Feng L, Zhu RD, Wu Y, Satish L, Siang Gan B et al. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Exp Cell Res 2009; 315: 3574–3586.
Hindocha S, John S, Stanley JK, Watson SJ, Bayat A . The heritability of Dupuytren's disease: familial aggregation and its clinical significance. J Hand Surg 2006; 31: 204–210.
Hindocha S, McGrouter DA, Bayat A . Epidemiological evaluation of Dupuytren's disease: incidence and prevalence rates in relation to etiology. Hand 2009; 4: 256–269.
Smith BH . Peyronie's disease. Am J Clin Pathol 1966; 45: 670–678.
Williams JL, Thomas GG . The natural history of Peyronie's disease. Proc Roy Soc Med 1968; 61: 876.
Chilton CP, Castle WM, Westwood CA, Pryor JP . Factors associated in the aetiology of Peyronie's disease. Br J Urol Int 1982; 54: 748–750.
Carrieri MP, Serraino D, Palmiotto F, Nucci G, Sasso F . A case-control study on risk factors for Peyronie's disease. J Clin Epidemiology 1998; 51: 511–515.
Perimenis P, Athanasasopoulos A, Gyftopoulos K, Jatsenis G, Barbalias G . Peyronie's disease: epidemiology and clinical presentation of 134 cases. Int Urol Nephrol 2001; 32: 691–694.
Johnson HM, Weerakoon P, Stricker PD . The incidence, aetiology, and presentation of Peyronie's disease in Sydney, Australia. J Sex Disability 2002; 20: 109–116.
Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S . A retrospective review of 307 men with Peyronie's disease. J Urol 2002; 168: 1075–1079.
Levine LA, Estrada CR, Storm DW, Markov TG . Peyronie's disease in younger men: characteristics and treatment Results. J Androl 2003; 24: 27–32.
Bjecic MD, Vlajinac HD, Sipetic SB, Marinkovic JM . Risk factors for Peyronie's disease: a case-control study. B J Urol Int 2006; 97: 570–574.
Deveci S, Hopps CV, O'Brien K, Parker M, Guhring P, Mulhall JP . Defining the clinical characteristics of Peyronie's disease in young men. J Sex Med 2007; 4: 485–490.
Rhoden EL, Riedner CE, Fuchs S, Ribeiro EP, Halmenschlager G . A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease. J Sex Med 2010; 7: 1529–1537.
Tefekli A, Kandirali E, Erol H, Alp T, Köksal T, Kadio∂lu A . Peyronie's disease in men under age 40: L characteristics and outcome. Int J Impot Res 2001; 13: 18–23.
Ziegelbaum M, Thomas A, Zachary AA . The association of Peyronie's disease with HLA B7 cross-reacting antigens. A case report of identical twins. Cleve Clin J Med 1987; 54: 427.
Bias WB, Nyberg Jr LM, Hochberg MC, Walsh PC . Peyronie's disease: a newly recognized autosomal-dominant trait. Am J Med Genet 1982; 12: 227–235.
The authors declare no conflict of interest.
About this article
Cite this article
Nugteren, H., Nijman, J., de Jong, I. et al. The association between Peyronie's and Dupuytren's disease. Int J Impot Res 23, 142–145 (2011). https://doi.org/10.1038/ijir.2011.18
This article is cited by
World Journal of Urology (2020)
Nature Reviews Urology (2019)
Tijdschrift voor Urologie (2018)
Current Urology Reports (2016)
Current Urology Reports (2014)